Amifostine |
0.2 g/kg |
Doxorubicin 0.003 g/kg |
Prepubertal rat (pnd 6) |
In vivo |
No protective effects |
Jahnukainen et al. (2001), Hou et al. (2005) |
Amifostine |
0.4 g/kg |
Cisplatin 0.005 g/kg |
Prepubertal rat (pnd 30) |
In vivo |
Partial protection, ↓ seminiferous tubule area and ↑ apoptotic spermatogonia and primary spermatocytes |
Lirdi et al. (2008) |
Amifostine |
0.4 g/kg |
Doxorubicin 0.005 g/kg |
Prepubertal rat (pnd 30) |
In vivo |
Partially protects. Did not protect against DNA damage and negatively impacted on embryo development and pregnancy outcome |
Vendramini et al. (2010, 2012) |
Amifostine |
1 µM |
Doxorubicin 0.01–1 µM (24 h) |
GC-6 spermatogonial and Ser-W3 immature SC cell line (rat) |
In vitro |
Pre-treatment for 24 h or co-treatment had no impact on cytotoxicity in the Ser-W3 cell line |
Tremblay & Delbes (2018) |
Cartinine |
0.25 g/kg |
Etoposide 0.04 g/kg |
Prepubertal rat (pnd25) |
In vivo |
Analysed pnd 30, 64 and 100. Partial protection, reduction in TUNEL+ cells |
Okada et al. (2009) |
Cartinine |
0.25 g/kg/day |
Doxorubicin 0.005 g/kg |
Prepubertal rat (pnd30) |
In vivo |
Analysed pnd 64 and 100. Partial protection, ↓ TUNEL+ cells and sperm DNA damage. ↑ Acrosome integrity pre-treatment, no impact on sperm motility and mitochondrial activity. ↓ Lipid peroxidation and nitric oxide. ↑ Fertility index and implantation rate improved |
Cabral et al. (2014, 2018) |
Cartinine |
10 mM |
Doxorubicin 0.01–1 µM (24 h) |
GC-6 spermatogonial and Ser-W3 immature SC cell line (rat) |
In vitro |
Pre-treatment for 24 h or co-treatment had no impact on cytotoxicity in the Ser-W3 cell line |
Tremblay & Delbes (2018) |
Curcumin |
5 µM |
Doxorubicin 0.01–1 µM (24 h) |
GC-6 spermatogonial and Ser-W3 immature SC cell line (rat) |
In vitro |
Pre-treatment for 24 h or co-treatment had no impact on cytotoxicity in the Ser-W3 cell line |
Tremblay & Delbes (2018) |
Ginseng intestinal metabolite I (GIM-I) |
0.05 g/kg/day |
Doxorubicin 0.05 g/kg/day |
Prepubertal rat (pnd28) |
In vivo |
Partially protects |
Kang et al. (2002) |
Vitamin C |
40 µg/mL |
Doxorubicin 0.01–1 µM (24 h) |
GC-6 spermatogonial and Ser-W3 immature SC cell line (rat) |
In vitro |
Pre-treatment for 24 h or co-treatment had no impact on cytotoxicity in the Ser-W3 cell line |
Tremblay & Delbes (2018) |